Healthcare provider profile · identity verified

Howard George Slemons, D.O.

Family Practice · HUBBARD, OH · NPI 1154410686

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	807	229
Atorvastatin Calcium	Atorvastatin Calcium	767	209
Amlodipine Besylate	Amlodipine Besylate	653	171
Losartan Potassium	Losartan Potassium	586	155
Levothyroxine Sodium	Levothyroxine Sodium	541	138
Pantoprazole Sodium	Pantoprazole Sodium	434	121
Lisinopril	Lisinopril	408	108
Metoprolol Succinate	Metoprolol Succinate	393	104
Metformin Hcl Er	Metformin Hcl	371	98
Metoprolol Tartrate	Metoprolol Tartrate	238	68
Omeprazole	Omeprazole	233	64
Escitalopram Oxalate	Escitalopram Oxalate	225	66
Azithromycin	Azithromycin	220	182
Eliquis	Apixaban	205	33
Hydrochlorothiazide	Hydrochlorothiazide	204	57
Potassium Chloride	Potassium Chloride	201	58
Furosemide	Furosemide	184	70
Donepezil Hcl	Donepezil Hcl	161	39
Simvastatin	Simvastatin	153	42
Carvedilol	Carvedilol	144	36
Metformin Hcl	Metformin Hcl	138	45
Tamsulosin Hcl	Tamsulosin Hcl	135	42
Synthroid	Levothyroxine Sodium	128	37
Albuterol Sulfate Hfa	Albuterol Sulfate	127	56
Glimepiride	Glimepiride	127	38
Doxycycline Hyclate	Doxycycline Hyclate	126	95
Meloxicam	Meloxicam	126	45
Valsartan	Valsartan	126	32
Gabapentin	Gabapentin	122	37
Pravastatin Sodium	Pravastatin Sodium	121	34
Allopurinol	Allopurinol	114	30
Atenolol	Atenolol	108	26
Clopidogrel	Clopidogrel Bisulfate	108	30
Sertraline Hcl	Sertraline Hcl	103	33
Cephalexin	Cephalexin	100	77
Ezetimibe	Ezetimibe	99	26
Trazodone Hcl	Trazodone Hcl	92	26
Glipizide Er	Glipizide	88	26
Meclizine Hcl	Meclizine Hcl	82	47
Triamcinolone Acetonide	Triamcinolone Acetonide	81	51
Amoxicillin	Amoxicillin	79	67
Prednisone	Prednisone	78	50
Methylprednisolone	Methylprednisolone	77	66
Ozempic	Semaglutide	76	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	75	13
Doxazosin Mesylate	Doxazosin Mesylate	71	19
Paroxetine Hcl	Paroxetine Hcl	70	19
Fluticasone Propionate	Fluticasone Propionate	69	37
Memantine Hcl	Memantine Hcl	69	11
Duloxetine Hcl	Duloxetine Hcl	67	19
Irbesartan	Irbesartan	65	16
Olmesartan Medoxomil	Olmesartan Medoxomil	62	16
Montelukast Sodium	Montelukast Sodium	61	16
Hydralazine Hcl	Hydralazine Hcl	60	16
Farxiga	Dapagliflozin Propanediol	57	suppressed
Nystatin	Nystatin	56	24
Warfarin Sodium	Warfarin Sodium	55	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	53	13
Jardiance	Empagliflozin	52	11
Alprazolam	Alprazolam	51	17
Lorazepam	Lorazepam	51	18
Bumetanide	Bumetanide	48	14
Cefdinir	Cefdinir	48	36
Celecoxib	Celecoxib	48	14
Fluconazole	Fluconazole	44	21
Paxlovid	Nirmatrelvir/Ritonavir	43	42
Citalopram Hbr	Citalopram Hydrobromide	42	12
Telmisartan	Telmisartan	39	suppressed
Ibuprofen	Ibuprofen	38	15
Xarelto	Rivaroxaban	38	suppressed
Famotidine	Famotidine	37	11
Valacyclovir	Valacyclovir Hcl	36	21
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Tramadol Hcl	Tramadol Hcl	34	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	33	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	32	suppressed
Torsemide	Torsemide	32	suppressed
Glipizide	Glipizide	31	suppressed
Alendronate Sodium	Alendronate Sodium	30	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	30	26
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Clonidine Hcl	Clonidine Hcl	29	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	27	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Ramipril	Ramipril	27	suppressed
Finasteride	Finasteride	26	suppressed
Klor-Con M20	Potassium Chloride	26	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	24
Enalapril Maleate	Enalapril Maleate	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Sucralfate	Sucralfate	25	suppressed
Colchicine	Colchicine	24	11
Etodolac	Etodolac	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	23	suppressed
Ipratropium Bromide	Ipratropium Bromide	22	suppressed
Naproxen	Naproxen	22	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Mupirocin	Mupirocin	21	13
Ibandronate Sodium	Ibandronate Sodium	20	suppressed
Lansoprazole	Lansoprazole	20	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	19	suppressed
Paxlovid (Eua)	Nirmatrelvir/Ritonavir	19	19
Benazepril Hcl	Benazepril Hcl	18	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	18	suppressed
Clotrimazole	Clotrimazole	18	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	16	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Doxepin Hcl	Doxepin Hcl	15	suppressed
Sildenafil Citrate	Sildenafil Citrate	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Glyburide	Glyburide	14	suppressed
Tradjenta	Linagliptin	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Epinephrine	Epinephrine	12	suppressed
Repaglinide	Repaglinide	12	suppressed
Risperidone	Risperidone	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Jantoven	Warfarin Sodium	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	11	suppressed
Tobramycin	Tobramycin	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error